Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-016459
Filing Date
2025-05-13
Accepted
2025-05-13 16:13:38
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20250331_10q.htm   iXBRL 10-Q 1401464
2 EXHIBIT 31.1 ex_769264.htm EX-31.1 16039
3 EXHIBIT 31.2 ex_769265.htm EX-31.2 16370
4 EXHIBIT 32.1 ex_769266.htm EX-32.1 12324
  Complete submission text file 0001437749-25-016459.txt   6991582

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20250331.xsd EX-101.SCH 61971
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20250331_cal.xml EX-101.CAL 45440
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20250331_def.xml EX-101.DEF 419002
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20250331_lab.xml EX-101.LAB 367367
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20250331_pre.xml EX-101.PRE 452929
78 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20250331_10q_htm.xml XML 1078776
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 25940257
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)